In an asymptomatic patient with serum sodium of 125 mmol/L who is on psychiatric medications, what are the potential causes of hyponatraemia and which signs or symptoms should be monitored?

Hyponatremia (Na 125 mmol/L) in Asymptomatic Psychiatric Patient: Causes and Monitoring

In an asymptomatic psychiatric patient with sodium of 125 mmol/L, the most likely cause is medication-induced SIADH from psychiatric drugs (particularly quetiapine, SSRIs, or SNRIs), and you should immediately check volume status, urine osmolality, urine sodium, and serum osmolality to confirm the diagnosis while monitoring for neurological symptoms that can rapidly progress to seizures or coma.

Primary Diagnostic Approach

Your first step is determining the type of hyponatremia through volume status assessment and biochemical testing 1:

Essential Laboratory Tests

• Serum osmolality (expect <275 mOsm/kg in SIADH)
• Urine osmolality (inappropriately high >300-500 mOsm/kg in SIADH)
• Urine sodium (>20-40 mEq/L in SIADH)
• Serum uric acid (<4 mg/dL suggests SIADH)
• TSH and cortisol (exclude hypothyroidism and adrenal insufficiency)
• Serum creatinine (assess renal function)

Volume Status Assessment

Clinically assess for:

• Euvolemic: No edema, normal skin turgor, normal jugular venous pressure → suggests SIADH
• Hypovolemic: Dry mucous membranes, decreased skin turgor, orthostatic hypotension → suggests diuretic overuse or salt wasting
• Hypervolemic: Edema, ascites, elevated JVP → suggests heart failure or cirrhosis

Potential Causes in Psychiatric Patients

Medication-Induced SIADH (Most Common)

High-risk psychiatric medications 2, 3, 4:

• Quetiapine (OR 2.11) - particularly dangerous when combined with polydipsia 5
• SSRIs: Venlafaxine (OR 5.99), paroxetine (OR 4.93), sertraline (OR 4.15), citalopram/escitalopram (OR 3.49), fluoxetine (OR 3.40)
• Tricyclic antidepressants: Clomipramine (OR 4.50)
• Mirtazapine (OR 2.83)
• Carbamazepine and oxcarbazepine (if used for mood stabilization) 6, 7

Risk factors for medication-induced hyponatremia 3:

• Advanced age (mean age 56 years in psychiatric patients with hyponatremia)
• Female gender
• First 2 weeks of treatment (highest risk period)
• Concurrent medications
• Medical comorbidities

Primary Polydipsia

Common in schizophrenia patients 5, 8:

• Excessive water intake (>3-4 L/day)
• Dangerous when combined with SIADH-inducing medications - can cause extreme hyponatremia (Na as low as 97 mmol/L reported) 5
• Look for: history of excessive water drinking, polyuria when not hyponatremic

Other Causes to Exclude

• Seizure disorders (OR 3.14) 2
• Hypothyroidism or adrenal insufficiency 1
• Diuretic use (thiazides particularly)
• Underlying medical conditions: heart failure, cirrhosis, renal disease

Critical Signs and Symptoms to Monitor

At Sodium 125-130 mEq/L (Current Level)

Even though asymptomatic now, patients typically experience 1:

• General weakness
• Confusion or subtle cognitive changes
• Headache
• Nausea

Critical warning: These symptoms can be mistaken for psychiatric symptoms, delaying recognition 8.

Progression to Severe Hyponatremia (<120 mEq/L)

Life-threatening manifestations 1, 5:

• Seizures
• Coma
• Obtundation/somnolence
• Cardiorespiratory distress
• Fixed gaze palsy
• Rigid, flexed posture
• Cerebral edema (on imaging)

Chronic Hyponatremia Complications

Even mild chronic hyponatremia causes 9:

• Cognitive impairment
• Gait disturbances
• Increased falls (23.8% vs 16.4% in normal sodium)
• Increased fractures (23.3% vs 17.3%)
• Secondary osteoporosis

Immediate Management Considerations

For Asymptomatic Sodium 125 mmol/L

Based on volume status 10, 11:

If Euvolemic (SIADH suspected):

• Continue monitoring closely - do NOT water restrict at this level 11
• Check electrolytes every 1-2 days
• Review and consider stopping offending psychiatric medication if safe
• Free water restriction (<1 L/day) only if sodium drops to 120-125 mmol/L 1, 10

If Hypovolemic (diuretic-induced):

• Stop diuretics immediately 12
• Volume expansion with normal saline
• Monitor for rebound

If patient has polydipsia:

• Fluid restriction to 1-1.5 L/day 12, 10
• Behavioral interventions
• Consider switching psychiatric medications

Critical Pitfalls to Avoid

1. Do NOT correct sodium >8-10 mmol/L in 24 hours 12, 13, 14 - risk of osmotic demyelination syndrome (ODS), which causes permanent neurological damage

   • Target correction: 4-6 mmol/L per 24 hours 13
   • Maximum: 8 mmol/L per 24 hours in high-risk patients 13

2. Do NOT use hypertonic saline unless severely symptomatic 10, 13 - reserved for seizures, coma, or acute symptomatic hyponatremia

3. Do NOT assume psychiatric symptoms are purely psychiatric 8 - confusion, agitation, lethargy may be hyponatremia

4. Do NOT water restrict at sodium 125 mmol/L if euvolemic 11 - may worsen effective hypovolemia and stimulate more ADH release

5. Monitor more frequently in first 2 weeks of new psychiatric medications 3 - highest risk period

Prognosis Considerations

Psychiatric patients with severe hyponatremia have better outcomes than non-psychiatric patients 8:

• In-hospital mortality: 0% vs 17% in non-psychiatric patients
• Younger age at presentation (55 vs 74 years)
• More likely due to reversible causes (polydipsia, medications)

However, hyponatremia in any patient increases mortality and hospital stay 9, making prompt recognition and appropriate management essential.